Showing 1 - 4 results of 4 for search 'Oh, ST', query time: 0.03s
Refine Results
-
1
Defining disease modification in myelofibrosis in the era of targeted therapy by Pemmaraju, N, Verstovsek, S, Mesa, R, Gupta, V, Garcia, JS, Scandura, JM, Oh, ST, Passamonti, F, Döhner, K, Mead, AJ
Published 2022Journal article -
2
Symptomatic benefit of momelotinib in patients with myelofibrosis: results from the SIMPLIFY phase III studies by Mesa, RA, Hudgens, S, Floden, L, Harrison, CN, Palmer, J, Gupta, V, McLornan, DP, McMullin, MF, Kiladjian, J-J, Foltz, L, Platzbecker, U, Fox, ML, Mead, AJ, Ross, DM, Oh, ST, Perkins, A, Leahy, MF, Deheshi, S, Donahue, R, Klencke, BJ, Verstovsek, S
Published 2023Journal article -
3
MOMENTUM: momelotinib vs danazol in patients with myelofibrosis previously treated with JAKi who are symptomatic and anemic by Verstovsek, S, Chen, C-C, Egyed, M, Ellis, M, Fox, L, Goh, YT, Gupta, V, Harrison, C, Kiladjian, J-J, Lazaroiu, MC, Mead, A, McLornan, D, McMullin, MF, Oh, ST, Perkins, A, Platzbecker, U, Scheid, C, Vannucchi, A, Yoon, S-S, Kowalski, MM, Mesa, RA
Published 2021Journal article -
4
Determining the recommended dose of pacritinib: results from the PAC203 dose-finding trial in advanced myelofibrosis by Gerds, AT, Savona, MR, Scott, BL, Talpaz, M, Egyed, M, Harrison, CN, Yacoub, A, Vannucchi, A, Mead, AJ, Kiladjian, J-J, O'Sullivan, J, García-Gutiérrez, V, Bose, P, Rampal, RK, Miller, CB, Palmer, J, Oh, ST, Buckley, SA, Mould, DR, Ito, K, Tyavanagimatt, S, Smith, JA, Roman-Torres, K, Devineni, S, Craig, AR, Mascarenhas, JO
Published 2020Journal article